Estimating the financial losses due to bovine fasciolosis in Switzerland.
about
Activity of OZ78 analogues against Fasciola hepatica and Echinostoma caproniTime-Course Study of the Transcriptome of Peripheral Blood Mononuclear Cells (PBMCs) from Sheep Infected with Fasciola hepaticaFasciola hepatica calcium-binding protein FhCaBP2: structure of the dynein light chain-like domainTegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycansAnimal health aspects of adaptation to climate change: beating the heat and parasites in a warming Europe.Liver fluke (Fasciola hepatica) infection in cattle in Northern Ireland: a large-scale epidemiological investigation utilising surveillance data.Rumen fluke (Calicophoron daubneyi) on Welsh farms: prevalence, risk factors and observations on co-infection with Fasciola hepatica.Combining Slaughterhouse Surveillance Data with Cattle Tracing Scheme and Environmental Data to Quantify Environmental Risk Factors for Liver Fluke in CattleFascioliasis risk factors and space-time clusters in domestic ruminants in Bangladesh.Associations between fasciolosis and milk production, and the impact of anthelmintic treatment in dairy herds.Estimating the total cost of bovine fasciolosis in Turkey.The activity of dispiro peroxides against Fasciola hepatica.Prevalence, risk factors and spatial analysis of liver fluke infections in Danish cattle herds.Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver.Development of a multiplex fluorescence immunological assay for the simultaneous detection of antibodies against Cooperia oncophora, Dictyocaulus viviparus and Fasciola hepatica in cattleDetermining the Prevalence and Seasonality of Fasciola hepatica in Pasture-based Dairy herds in Ireland using a Bulk Tank Milk ELISA.Epidemiology and impact of Fasciola hepatica exposure in high-yielding dairy herds.In vitro tegumental alterations on adult Fasciola gigantica caused by mefloquine.Dot-blot immunoassay of Fasciola gigantica infection using 27 kDa and adult worm regurge antigens in Egyptian patients.Interleukin-25 Induces Resistance Against Intestinal TrematodesRelative importance of meteorological and geographical factors in the distribution of Fasciola hepatica infestation in farmed sheep in Qinghai province, ChinaNew insight in lymnaeid snails (Mollusca, Gastropoda) as intermediate hosts of Fasciola hepatica (Trematoda, Digenea) in Belgium and Luxembourg.The global burden of fasciolosis in domestic animals with an outlook on the contribution of new approaches for diagnosis and control.Recent advances in the diagnosis, impact on production and prediction of Fasciola hepatica in cattle.Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance.Fasciola hepatica infection and association with gastrointestinal parasites in Creole goats from western Argentina.Longitudinal study on the temporal and micro-spatial distribution of Galba truncatula in four farms in Belgium as a base for small-scale risk mapping of Fasciola hepatica.Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep.Genetic parameters for both a liver damage phenotype caused by and antibody response to phenotype in dairy and beef cattle.FhCaBP2: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains.Is Galba schirazensis (Mollusca, Gastropoda) an intermediate host of Fasciola hepatica (Trematoda, Digenea) in Ecuador?Assessment of a 27-kDa antigen in enzyme-linked immunosorbent assay for the diagnosis of fasciolosis in Vietnamese patients.Point prevalence of bovine fascioliasis and the influence of chemotherapy on the milk yield in a lactating bovine population from the district of Toba Tek Singh, Pakistan.Phenotypes of intermediate forms of Fasciola hepatica and F. gigantica in buffaloes from Central Punjab, Pakistan.Seroprevalence and GIS-supported risk factor analysis of Fasciola hepatica infections in dairy herds in Germany.Efficacy against Fasciola hepatica and the pharmacokinetics of triclabendazole administered by oral and topical routes.Scientific Opinion on the public health hazards to be covered by inspection of meat (bovine animals)Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins.Farm-level risk factors for Fasciola hepatica infection in Danish dairy cattle as evaluated by two diagnostic methods.Seasonal pattern of Fasciola hepatica antibodies in dairy herds in Northern Germany.
P2860
Q24630199-4C9F6620-400D-4F98-9E7E-9B053C89858BQ27334595-930A60B3-0C51-473F-9862-01FE7CC466C8Q27704642-4C131069-FDF7-49A1-8F8C-6AF61467BC8AQ28551767-D340C3EF-FCA1-41A5-A973-A46FB5209B7DQ30641344-4F972D84-4BEE-4283-A9A1-CFCFB4124F7AQ31077520-574EB394-6F58-41F7-A31D-2E199B30ADCEQ31140233-50304648-EBE6-48E4-8EB6-7701DE679084Q33646568-61649ED9-2A7F-4A4D-8619-CD680F53AFE3Q33651535-E04AD57E-032B-4673-8A45-5A0563AC96B1Q33840886-A695B5CA-0490-45DF-B9E5-2C1FE7F59DC5Q33908386-8F5B7871-8E67-4CB6-BB9F-07B4D47EC6D9Q35175961-6938ABAB-C1A2-4E1D-AEF5-AB8B1799A98CQ35218492-16B9252A-7698-4F98-825B-7472322599B1Q35246561-B813D910-0A31-4921-B10F-7C7811CAA2A9Q35819700-D6E1C642-9371-4987-82AD-C57B10EB72E3Q35830674-7A2B5422-D3DC-4F51-8B8F-540559D95B1EQ35925661-0AA34176-0E11-49F5-A1FF-C9E228ECA909Q36750810-AAB262A0-580C-4910-8047-763994683D37Q36869077-1DE759E3-3D4C-4603-BE7C-774E569745D8Q37277961-03608D92-B6AE-4279-AB8C-F4B90718B98AQ37527018-ECEDDC5F-61DA-4F48-9758-080364742BCBQ37588138-6384FA0F-93BE-46D3-95D0-54A35B5EEA4BQ38111242-073C246B-AC82-4CF3-ABBB-281272FA6BB4Q38162536-DDBC8D49-2B32-4EC0-A8FB-A4E96BD833C8Q38784552-33DF8488-5404-475A-8A5A-AD3F727FD870Q38957390-8372F2ED-702E-4653-A72F-33D0B9BA2A82Q39094087-965D9236-9FAC-46DE-9F17-729D7C1B1569Q39126668-43F116B4-88F1-4F48-BE5D-D5F781ECCD59Q39145158-17E39747-9DBD-4E21-ABFB-6CDF14D0947AQ39521198-940431E1-04D6-41FD-90F0-8C9854C30FABQ40140044-9921A539-6742-4C39-A5EC-68050B2960ADQ43165357-C09346FF-FB96-4003-9342-06393B824547Q43807532-CC01874D-5429-4E7F-9DB5-D2A7E1864977Q43928506-54E8D3F8-0619-4EA4-9AC0-A1C5EE721974Q44353470-AC06ACD9-400D-4BFC-B3F7-F89DC86BC03AQ46042414-4608236E-8618-47B6-A91E-8AF47E932405Q47153429-81242788-E179-4C83-931E-6C003CF70B39Q47378690-7C3D4538-A30F-4525-B40E-E5E259495401Q47623796-A79EBC71-1874-43FA-8892-20B33445D090Q53109264-0F282901-5CEB-4C2A-86FE-1B38A23CD706
P2860
Estimating the financial losses due to bovine fasciolosis in Switzerland.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Estimating the financial losses due to bovine fasciolosis in Switzerland.
@en
Estimating the financial losses due to bovine fasciolosis in Switzerland.
@nl
type
label
Estimating the financial losses due to bovine fasciolosis in Switzerland.
@en
Estimating the financial losses due to bovine fasciolosis in Switzerland.
@nl
prefLabel
Estimating the financial losses due to bovine fasciolosis in Switzerland.
@en
Estimating the financial losses due to bovine fasciolosis in Switzerland.
@nl
P2093
P356
P1433
P1476
Estimating the financial losses due to bovine fasciolosis in Switzerland.
@en
P2093
Schweizer G
Torgerson PR
P304
P356
10.1136/VR.157.7.188
P407
P577
2005-08-01T00:00:00Z